Catalyst Pharmaceuticals, Inc.

NasdaqCM:CPRX Stock Report

Market Cap: US$2.8b

Catalyst Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CPRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Jun 25SellUS$103,649Preethi SundaramIndividual3,924US$26.42
09 Jun 25SellUS$5,217,338Patrick McEnanyIndividual200,000US$26.11
30 May 25SellUS$1,740,200Richard John DalyIndividual70,000US$24.86
03 Mar 25SellUS$696,382Jeffrey Del CarmenIndividual30,423US$22.89
03 Mar 25SellUS$10,454Brian ElsberndIndividual450US$23.23
20 Aug 24SellUS$3,052,900Steven MillerIndividual150,000US$20.59
09 Aug 24SellUS$111,710Jeffrey Del CarmenIndividual6,058US$18.44

Insider Trading Volume

Insider Buying: CPRX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CPRX?
Owner TypeNumber of SharesOwnership Percentage
State or Government49,7990.0408%
Individual Insiders7,325,1726.01%
General Public14,827,72912.2%
Institutions99,772,45281.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 58.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.4%
BlackRock, Inc.
18,804,055US$428.9m-3.2%0.01%
6.97%
The Vanguard Group, Inc.
8,495,580US$193.8m0.76%no data
4.53%
State Street Global Advisors, Inc.
5,530,437US$126.1m-4.59%no data
3.51%
Patrick McEnany
4,281,702US$97.7m-28.6%no data
2.81%
Deerfield Management Company, L.P. Series C
3,422,149US$78.1m9.23%1.57%
2.42%
Renaissance Technologies LLC
2,956,316US$67.4m9.25%0.1%
2.27%
Geode Capital Management, LLC
2,765,556US$63.1m3.75%no data
1.79%
Dimensional Fund Advisors LP
2,187,422US$49.9m-27.4%0.01%
1.76%
Fundsmith, LLP
2,151,274US$49.1m0%0.17%
1.63%
Morgan Stanley, Investment Banking and Brokerage Investments
1,983,668US$45.2m17.3%no data
1.45%
Goldman Sachs Group, Investment Banking and Securities Investments
1,769,377US$40.4m26.5%0.02%
1.31%
Royce & Associates, LP
1,598,360US$36.5m-14.3%0.36%
1.25%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,525,527US$34.8m18%0.01%
1.22%
Northern Trust Global Investments
1,486,198US$33.9m-1.16%no data
1.12%
Goldman Sachs Asset Management, L.P.
1,366,096US$31.2m-2.7%0.01%
1.09%
Charles Schwab Investment Management, Inc.
1,326,771US$30.3m6.4%no data
1.05%
UBS Asset Management AG
1,285,701US$29.3m30.3%no data
1.05%
Boston Partners Global Investors, Inc.
1,275,325US$29.1m-1.28%0.02%
0.87%
Kennedy Capital Management LLC
1,061,323US$24.2m4.29%0.57%
0.86%
Invesco Capital Management LLC
1,051,323US$24.0m50.5%0.01%
0.85%
Arrowstreet Capital, Limited Partnership
1,035,029US$23.6m48.3%0.02%
0.8%
T. Rowe Price Group, Inc.
977,623US$22.3m-19.6%no data
0.78%
Steven Miller
949,663US$21.7m1.46%no data
0.77%
Macquarie Investment Management Business Trust
934,299US$21.3m36.9%0.03%
0.7%
Pacer Advisors, Inc.
854,367US$19.5m-71.1%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/20 20:36
End of Day Share Price 2025/06/18 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Catalyst Pharmaceuticals, Inc. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joel BeattyBaird
Jason Matthew GerberryBofA Global Research
Charles DuncanCantor Fitzgerald & Co.